Jump to main content
Jump to site search

Issue 58, 2014
Previous Article Next Article

Smart drug delivery systems: from fundamentals to the clinic

Author affiliations


Forty years after the first reports on stimuli-responsive phase transitions in synthetic hydrogels, the first medicines based on responsive components are approaching the market. Sensitiveness to internal or external signals of the body can be achieved by means of materials (mostly polymers, but also lipids and metals) that modify their properties as a function of the intensity of the signal and that enable the transduction into changes in the delivery system that affect its ability to host/release a therapeutic substance. Integration of responsive materials into implantable depots, targetable nanocarriers and even insertable medical devices can endow them with activation-modulated and feedback-regulated control of drug release. This review offers a critical overview of therapeutically-interesting stimuli to trigger drug release and the evolution of responsive materials suitable as functional excipients, illustrated with recent examples of formulations in clinical trials or already commercially available, which can provide a perspective on the current state of the art on smart drug delivery systems.

Graphical abstract: Smart drug delivery systems: from fundamentals to the clinic

Back to tab navigation

Article information

24 Feb 2014
23 Apr 2014
First published
23 Apr 2014

Chem. Commun., 2014,50, 7743-7765
Article type
Feature Article
Author version available

Smart drug delivery systems: from fundamentals to the clinic

C. Alvarez-Lorenzo and A. Concheiro, Chem. Commun., 2014, 50, 7743
DOI: 10.1039/C4CC01429D

Social activity

Search articles by author